These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11411900)

  • 1. Synthesis and properties of dextran-nalidixic acid ester as a colon-specific prodrug of nalidixic acid.
    Lee JS; Jung YJ; Doh MJ; Kim YM
    Drug Dev Ind Pharm; 2001 Apr; 27(4):331-6. PubMed ID: 11411900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of dextran-flufenamic acid ester as a polymeric colon-specific prodrug of flufenamic acid, an anti-inflammatory drug, for chronotherapy.
    Lee Y; Kim IH; Kim J; Yoon JH; Shin YH; Jung Y; Kim YM
    J Drug Target; 2011 Jun; 19(5):336-43. PubMed ID: 20615092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and properties of dextran-5-aminosalicylic acid ester as a potential colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Lee JS; Kim HH; Kim YT; Kim YM
    Arch Pharm Res; 1998 Apr; 21(2):179-86. PubMed ID: 9875428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis.
    Varshosaz J; Emami J; Tavakoli N; Fassihi A; Minaiyan M; Ahmadi F; Dorkoosh F
    Int J Pharm; 2009 Jan; 365(1-2):69-76. PubMed ID: 18804521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes.
    Kim W; Yang Y; Kim D; Jeong S; Yoo JW; Yoon JH; Jung Y
    Drug Des Devel Ther; 2017; 11():419-429. PubMed ID: 28243064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro properties of dexamethasone 21-sulfate sodium as a colon-specific prodrug of dexamethasone.
    Kim IH; Kong HS; Choi BI; Kim YS; Kim HJ; Yang YW; Jung YJ; Kim YM
    Drug Dev Ind Pharm; 2006 Mar; 32(3):389-97. PubMed ID: 16556543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents.
    McLeod AD; Friend DR; Tozer TN
    J Pharm Sci; 1994 Sep; 83(9):1284-8. PubMed ID: 7530303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery.
    Lee Y; Kim J; Kim W; Nam J; Jeong S; Lee S; Yoo JW; Kim MS; Jung Y
    Drug Des Devel Ther; 2015; 9():4105-13. PubMed ID: 26251576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and properties of polysaccharide prodrugs of 5-aminosalicylic acid as potential colon-specific delivery systems.
    Zou M; Okamoto H; Cheng G; Hao X; Sun J; Cui F; Danjo K
    Eur J Pharm Biopharm; 2005 Jan; 59(1):155-60. PubMed ID: 15567313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, chemical and enzymatic hydrolysis, and bioavailability evaluation in rabbits of metronidazole amino acid ester prodrugs with enhanced water solubility.
    Mahfouz NM; Hassan MA
    J Pharm Pharmacol; 2001 Jun; 53(6):841-8. PubMed ID: 11428660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and properties of 5-aminosalicyl-taurine as a colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Kim HH; Kong HS; Kim YM
    Arch Pharm Res; 2003 Apr; 26(4):264-9. PubMed ID: 12735682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextran-5-(4-ethoxycarbonylphenylazo)salicylic acid ester, a polymeric colon-specific prodrug releasing 5-aminosalicylic acid and benzocaine, ameliorates TNBS-induced rat colitis.
    Nam J; Kim W; Lee S; Jeong S; Yoo JW; Kim MS; Jung Y
    J Drug Target; 2016; 24(5):468-74. PubMed ID: 26377354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macromolecular prodrugs. XX. Factors influencing model dextranase-mediated depolymerization of dextran derivatives in vitro.
    Nielsen LS; Weibel H; Johansen M; Larsen C
    Acta Pharm Nord; 1992; 4(1):23-30. PubMed ID: 1381183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro properties of prednisolone 21-sulfate sodium as a colon-specific prodrug of prednisolone.
    Doh MJ; Jung YJ; Kim Ih; Kong HS; Kim YM
    Arch Pharm Res; 2003 Apr; 26(4):258-63. PubMed ID: 12735681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis.
    Varshosaz J; Emami J; Ahmadi F; Tavakoli N; Minaiyan M; Fassihi A; Mahzouni P; Dorkoosh F
    J Drug Target; 2011 Feb; 19(2):140-53. PubMed ID: 20429772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metronidazole prodrugs: synthesis, physicochemical properties, stability, and ex vivo release studies.
    Mura C; Valenti D; Floris C; Sanna R; De Luca MA; Fadda AM; Loy G
    Eur J Med Chem; 2011 Sep; 46(9):4142-50. PubMed ID: 21726922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of site-specific delivery of dexamethasone-dextran prodrug in rat gastrointestinal tract].
    Zhou SY; Mei QB; Zhou J; Liu L; Li C; Zhao DH
    Yao Xue Xue Bao; 2001 May; 36(5):325-8. PubMed ID: 12584851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of drug-release in vitro of different dextran-dexamethasone conjugates].
    Zhou SY; Mei QB; Liu L; Zhang BL; Li C; Zhou J
    Yao Xue Xue Bao; 2003 May; 38(5):388-91. PubMed ID: 12958847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, colon-targeted studies and pharmacological evaluation of an anti-ulcerative colitis drug 4-Aminosalicylic acid-β-O-glucoside.
    Li F; Wu G; Zheng H; Wang L; Zhao Z
    Eur J Med Chem; 2016 Jan; 108():486-494. PubMed ID: 26717200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro evaluation of biphenylyl acetic acid-beta-cyclodextrin conjugates as colon-targeting prodrugs: drug release behaviour in rat biological media.
    Hirayama F; Minami K; Uekama K
    J Pharm Pharmacol; 1996 Jan; 48(1):27-31. PubMed ID: 8722490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.